Timeline

Voting rights breakdown

Notice details

Beneficial owner

Santhera Pharmaceuticals Holding Ltd

Santhera Pharmaceuticals Holding AG discloses in accordance with Article 20 of the Swiss Federal Act on Stock Exchanges and Securities Trading and the amendments to SESTO-FBC that came into force on December 1, 2007, that as of January 14, 2008, the Company has sale positions pursuant to Art. 13 para. 1 b SESTO-FBC of 301,509 granted share purchase rights consisting of 301,509 share option rights (according to employee and executive stock option plans) which entitle holders of options to purchase a total of 301,509 registered shares of the Company. These 301,509 share option rights would correspond to 8.82% of voting rights if exercised. The exercise period of all below listed options is 10 years from the date of grant and the exercise of each of the below listed options entitles to the acquisition of one of the Company’s shares. On the last grant the exercise price was CHF 95.70. Year of allocation Number of Options Exercise Price CHF 2002 6,054 1.00 2002 709 60.25 2003 32,860 59.44 2003 982 60.25 2004 11,091 1.00 2004 38,472 59.44 2004 8,999 60.25 2005 11,339 59.44 2006 96,344 1.00 2006 40,200 59.44 2006 6,300 82.58 2007 18,000 1.00 2007 11,339 59.44 2007 1,600 89.80 2007 2,900 101.80 2007 10,000 106.80 2007 320 114.50 2008 4,000 95.70